How inflammation affects liver function and insulin sensitivity

Innate immune regulation of hepatic insulin sensitivity and metabolism

NIH-funded research Ut Southwestern Medical Center · NIH-10868739

This study is looking at how inflammation affects non-alcoholic fatty liver disease (NAFLD) and aims to understand how certain immune factors might help us find new ways to treat this common liver condition that currently has no approved medications.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionUt Southwestern Medical Center NIH-funded
Lab location1 site (Dallas, United States)
Project IDNIH-10868739 on NIH RePORTER

What this research studies

This research investigates the role of inflammation in non-alcoholic fatty liver disease (NAFLD), a common chronic liver condition without FDA-approved treatments. It focuses on how certain immune factors, specifically interferon regulatory factors (IRFs), influence liver metabolism and insulin signaling. By studying mice with modified IRF3 genes, the research aims to uncover the mechanisms by which inflammation leads to insulin resistance and fat accumulation in the liver. Patients may benefit from insights that could lead to new therapeutic strategies for managing NAFLD.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with non-alcoholic fatty liver disease or those at risk due to obesity or metabolic syndrome.

Not a fit: Patients with alcoholic liver disease or other liver conditions unrelated to inflammation and insulin resistance may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for non-alcoholic fatty liver disease, improving liver health and insulin sensitivity for affected patients.

How similar studies have performed: Previous research has shown promising results in understanding the role of inflammation in metabolic diseases, suggesting that this approach could yield valuable insights.

Where this research is happening

Dallas, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.